The North Carolina not-for-profit healthcare system selected Omnicell's XT automated cabinets as it seeks to enhance patient-care on nursing floors and in perioperative settings. With our ...

Stereotaxis, Inc. STXS, a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, ...

The global pharmacy automation market is poised for exceptional growth, with market size projected to leap from USD 6.1 ...

For the current quarter ending in March, Omnicell expects its per-share earnings to range from 15 cents to 25 cents. The company said it expects revenue in the range of $255 million to $265 million ...

Omnicell anticipates 2025 total revenue to range from $1.105 million to $1.155 million, with product bookings expected between $500 million and $550 million and annual recurring revenue ( ARR) ...

Healthcare tech company Omnicell (NASDAQ:OMCL) will be reporting results tomorrow morning. Here’s what to expect. Omnicell beat analysts’ revenue expectations by 0.6% last quarter, reporting ...

In the latest quarter, 4 analysts provided ratings for Omnicell (NASDAQ:OMCL), showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below ...

Omnicell OMCL is advancing toward the industry-defined vision of Autonomous Pharmacy by leveraging automation and advanced services across its cloud-based platform. The strength of the company’s ...

In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Omnicell (OMCL – Research Report). The company’s shares ...

Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q4 CY2024 results , with sales up 18.6% year on year to $306.9 ...